EER | ENST | ENSG | GeneName | Region | Repeat | dsRNA structure | chr16:28608041-28608308:- | ENST00000314752.10 | ENSG00000196502.10 | SULT1A1 | exonic | AluSp | chr16:28608041-28608308:-.alignment |
chr16:28608041-28608308:- | ENST00000395607.4 | ENSG00000196502.10 | SULT1A1 | exonic | AluSp | chr16:28608041-28608308:-.alignment |
chr16:28608041-28608308:- | ENST00000395609.4 | ENSG00000196502.10 | SULT1A1 | exonic | AluSp | chr16:28608041-28608308:-.alignment |
chr16:28608041-28608308:- | ENST00000566189.4 | ENSG00000196502.10 | SULT1A1 | exonic | AluSp | chr16:28608041-28608308:-.alignment |
chr16:28608041-28608308:- | ENST00000567512.1 | ENSG00000196502.10 | SULT1A1 | exonic | AluSp | chr16:28608041-28608308:-.alignment |
chr16:28608041-28608308:- | ENST00000569554.4 | ENSG00000196502.10 | SULT1A1 | exonic | AluSp | chr16:28608041-28608308:-.alignment |
chr16:28609505-28609724:- | ENST00000567998.4 | ENSG00000196502.10 | SULT1A1 | ncRNA_exonic | AluJr4 | chr16:28609505-28609724:-.alignment |
chr16:28617040-28619731:- | ENST00000350842.7 | ENSG00000196502.10 | SULT1A1 | intronic | AluSz,AluJb,LTR84a,AluSc,L2c,AluSc8 | chr16:28617040-28619731:-.alignment |
chr16:28617040-28619731:- | ENST00000395609.4 | ENSG00000196502.10 | SULT1A1 | intronic | AluSz,AluJb,LTR84a,AluSc,L2c,AluSc8 | chr16:28617040-28619731:-.alignment |
chr16:28617040-28619731:- | ENST00000562058.4 | ENSG00000196502.10 | SULT1A1 | intronic | AluSz,AluJb,LTR84a,AluSc,L2c,AluSc8 | chr16:28617040-28619731:-.alignment |
chr16:28617040-28619731:- | ENST00000563493.1 | ENSG00000196502.10 | SULT1A1 | intronic | AluSz,AluJb,LTR84a,AluSc,L2c,AluSc8 | chr16:28617040-28619731:-.alignment |
chr16:28617040-28619731:- | ENST00000564818.4 | ENSG00000196502.10 | SULT1A1 | intronic | AluSz,AluJb,LTR84a,AluSc,L2c,AluSc8 | chr16:28617040-28619731:-.alignment |
ID_events | cancer | TypeID | ImmuneCell | P | R | CorrelationPlot |
ENSG00000196502.10,SULT1A1 | BLCA | EAG | Macrophages_M2 | 8.4266e-03 | -0.3318 |  |
chr16:28617040-28619731:- | BRCA | EER | Macrophages_M1 | 2.4541e-02 | 0.2482 |  |
ENSG00000196502.10,SULT1A1 | COAD | EAG | T_cells_CD4_naive | 1.9245e-02 | 0.4841 |  |
chr16:28617040-28619731:- | ESCA | EER | B_cells_naive | 3.3427e-02 | 0.3177 |  |
ENSG00000196502.10,SULT1A1 | KIRC | EAG | Dendritic_cells_activated | 7.5854e-03 | 0.4500 |  |
ENSG00000196502.10,SULT1A1 | KIRP | EAG | Mast_cells_activated | 5.1179e-04 | 0.5874 |  |
ENSG00000196502.10,SULT1A1 | LAML | EAG | T_cells_regulatory_(Tregs) | 8.3397e-03 | -0.2587 | .ENSG00000196502.10,SULT1A1.png) |
ENSG00000196502.10,SULT1A1 | LUSC | EAG | T_cells_CD4_memory_resting | 3.0163e-02 | 0.2238 |  |
chr16:28609505-28609724:- | OV | EER | T_cells_follicular_helper | 4.2088e-02 | -0.1814 |  |
ENSG00000196502.10,SULT1A1 | OV | EAG | Eosinophils | 2.3243e-02 | -0.1846 |  |
chr16:28609505-28609724:- | PCPG | EER | Mast_cells_resting | 1.6486e-03 | 0.6307 |  |
chr16:28617040-28619731:- | STAD | EER | Plasma_cells | 4.5912e-02 | 0.2609 |  |
ENSG00000196502.10,SULT1A1 | STAD | EAG | B_cells_memory | 4.5803e-02 | 0.2044 |  |
ENSG00000196502.10,SULT1A1 | THCA | EAG | B_cells_memory | 4.4646e-02 | -0.1648 |  |
ID_events | cancer | HallmarkType | Type | P | R | CorrelationPlot |
ENSG00000196502.10,SULT1A1 | BLCA | GSVA_HALLMARK_P53_PATHWAY | EAG | 1.0365e-03 | 0.4067 |  |
chr16:28617040-28619731:- | BRCA | GSVA_HALLMARK_PANCREAS_BETA_CELLS | EER | 5.4680e-03 | 0.3041 |  |
ENSG00000196502.10,SULT1A1 | BRCA | GSVA_HALLMARK_PANCREAS_BETA_CELLS | EAG | 9.6326e-07 | 0.2460 |  |
chr16:28608041-28608308:- | BRCA | GSVA_HALLMARK_ADIPOGENESIS | EER | 1.4994e-04 | 0.4565 |  |
ENSG00000196502.10,SULT1A1 | CESC | GSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY | EAG | 4.3437e-03 | 0.5314 |  |
ENSG00000196502.10,SULT1A1 | COAD | GSVA_HALLMARK_COAGULATION | EAG | 1.5958e-02 | 0.4965 |  |
chr16:28617040-28619731:- | ESCA | GSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALING | EER | 5.9365e-04 | -0.4922 |  |
ENSG00000196502.10,SULT1A1 | ESCA | GSVA_HALLMARK_PANCREAS_BETA_CELLS | EAG | 1.1787e-02 | 0.3130 |  |
ENSG00000196502.10,SULT1A1 | KIRC | GSVA_HALLMARK_HEDGEHOG_SIGNALING | EAG | 4.0473e-02 | 0.3532 |  |
ENSG00000196502.10,SULT1A1 | LUAD | GSVA_HALLMARK_BILE_ACID_METABOLISM | EAG | 3.7913e-02 | -0.2561 |  |
ENSG00000196502.10,SULT1A1 | LUSC | GSVA_HALLMARK_HEDGEHOG_SIGNALING | EAG | 1.7826e-02 | 0.2439 |  |
chr16:28617040-28619731:- | OV | GSVA_HALLMARK_HEME_METABOLISM | EER | 1.0772e-02 | 0.3097 |  |
chr16:28609505-28609724:- | OV | GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION | EER | 1.7218e-02 | 0.2119 |  |
chr16:28608041-28608308:- | OV | GSVA_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | EER | 3.2272e-02 | 0.4209 |  |
ENSG00000196502.10,SULT1A1 | OV | GSVA_HALLMARK_XENOBIOTIC_METABOLISM | EAG | 4.6178e-02 | 0.1625 |  |
chr16:28609505-28609724:- | PCPG | GSVA_HALLMARK_SPERMATOGENESIS | EER | 7.3585e-03 | 0.5548 |  |
ENSG00000196502.10,SULT1A1 | PRAD | GSVA_HALLMARK_UV_RESPONSE_DN | EAG | 2.2121e-02 | 0.2975 |  |
ENSG00000196502.10,SULT1A1 | THCA | GSVA_HALLMARK_ESTROGEN_RESPONSE_EARLY | EAG | 3.7222e-05 | 0.3311 |  |
ID_events | cancer | Drug | Type | P | R | CorrelationPlot |
ENSG00000196502.10,SULT1A1 | BLCA | CGP.60474 | EAG | 5.9816e-03 | -0.3453 |  |
chr16:28617040-28619731:- | BRCA | CCT018159 | EER | 2.5440e-02 | 0.2467 |  |
ENSG00000196502.10,SULT1A1 | BRCA | Lapatinib | EAG | 3.7780e-03 | -0.1477 |  |
ENSG00000196502.10,SULT1A1 | COAD | Dasatinib | EAG | 6.9884e-03 | -0.5464 |  |
chr16:28617040-28619731:- | ESCA | FH535 | EER | 2.0722e-05 | 0.5891 |  |
ENSG00000196502.10,SULT1A1 | ESCA | FH535 | EAG | 4.5736e-06 | 0.5379 |  |
ENSG00000196502.10,SULT1A1 | KIRC | AZD6482 | EAG | 1.6560e-02 | -0.4082 |  |
ENSG00000196502.10,SULT1A1 | KIRP | CGP.082996 | EAG | 2.8131e-02 | 0.3944 |  |
ENSG00000196502.10,SULT1A1 | LAML | ABT.263 | EAG | 1.5530e-03 | -0.3080 |  |
ENSG00000196502.10,SULT1A1 | LUAD | KIN001.135 | EAG | 1.9213e-04 | -0.4434 |  |
ENSG00000196502.10,SULT1A1 | LUSC | LFM.A13 | EAG | 1.2396e-02 | -0.2570 |  |
chr16:28609505-28609724:- | OV | MG.132 | EER | 3.2976e-03 | -0.2609 |  |
chr16:28608041-28608308:- | OV | Dasatinib | EER | 7.1004e-03 | -0.5150 |  |
ENSG00000196502.10,SULT1A1 | OV | MG.132 | EAG | 2.6372e-02 | -0.1813 |  |
chr16:28609505-28609724:- | PCPG | CHIR.99021 | EER | 2.2569e-05 | 0.7753 |  |
ENSG00000196502.10,SULT1A1 | PCPG | CHIR.99021 | EAG | 1.5181e-02 | 0.4192 |  |
chr16:28617040-28619731:- | STAD | FH535 | EER | 1.9876e-02 | 0.3025 |  |
ENSG00000196502.10,SULT1A1 | THCA | Lapatinib | EAG | 8.4377e-04 | -0.2706 |  |